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Abstract
The kinesin protein Kif7 has been recognized as an integral component of hedgehog signalling. Aberrant activation of
hedgehog signalling has been implicated in many human solid tumours. Gestational trophoblastic disease includes frankly
malignant choriocarcinoma and potentially malignant hydatidiform mole. Here we investigated the hedgehog signalling
components expression profiles in gestational trophoblastic disease. Downregulation of Gli1, Gli2, Gli3 and Kif7 was
demonstrated in clinical samples of choriocarcinoma and hydatidiform moles as well as choriocarcinoma cell lines when
compared with normal placentas. Ectopic expression of Kif7 in two choriocarcinoma cell lines JAR and JEG-3 led to a
decrease in cell growth and increase in apoptosis demonstrated by MTT and TUNEL assays, respectively. Overexpression of
Kif7 also led to suppressed cell migration through transwell assay. In contrast, knocking down Kif7 in HTR-8/SVneo, an
immortalized trophoblast cell line, increased cell number over time and increased the migratory ability of the cells. Taken
together, Kif7 may contribute to pathogenesis of gestational trophoblastic disease through enhancing survival and
promoting dissemination of trophoblasts.
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Introduction
Gestational trophoblastic disease (GTD) is a family of pregnan-
cy-related diseases characterized by abnormal proliferation of
placental trophoblasts [1,2]. There are at least five types of GTD
with distinct genetic, histopathological and clinical features:
hydatidiform mole (HM), invasive mole (IM), choriocarcinoma
(CCA), placental site trophoblastic tumour (PSTT), and epithelioid
trophoblastic tumour (ETT). HM is a relatively benign condition
whereas the others could be considered frankly malignant tumours
[3,4]. Although most HM can be successfully treated with suction
evacuation, a significant proportion (8–30%) of HM will
subsequently progress into malignant GTD, most commonly
CCA, and require chemotherapy. On the other hand, while more
than half of all CCA were developed from HM, CCA may also
develop de novo after normal pregnancy, spontaneous abortion or
ectopic pregnancy [5]. There is no definite predictor for malignant
progression of HM currently. Identification of patients at risk
hence relies on serial human chorionic gonadotropin (hCG)
monitoring after suction evacuation. Understanding the patho-
genesis of malignant GTD may reveal novel predictive biomarkers
and therapeutic targets.
Several lines of evidence suggested that the pathogenesis of
GTD may involve dysregulated stem cell activities [6]. For
instance, Oct4, a transcription factor critical for maintaining the
pluripotency of embryonic stem cells (ESCs), is downregulated in
HM and CCA by promoter hypermethylation [7]. Similarly, we
discovered that the methylation status of the promoter of SOX2,
which encodes a transcription factor critical for self-renewal
capacity of ESCs, was increased in GTD. This epigenetic change
was associated with downregulation of the corresponding
transcript and protein levels [8]. On the other hand, Stat3 and
Nanog are overexpressed in GTD and contribute to apoptosis
regulation and invasion capability of GTD trophoblasts [9,10].
These findings prompted us to ask whether other stem cell
regulation pathways are dysregulated in GTD.
The Hedgehog (HH) signalling pathway is essential for stem cell
maintenance and tissue development [11,12]. Aberrant activation
of HH signalling pathway has been documented in various human
malignancies including ovarian and endometrial carcinomas as
previously reported by our group [13–15]. In mammals, there are
three HH ligand proteins: Sonic Hedgehog (Shh), Indian
Hedgehog (Ihh) and Desert Hedgehog (Dhh). In the absence of
ligands, the transmembrane protein receptor Patched (Ptch)
inhibits another membrane protein Smoothened (Smo) from
activating downstream signalling [16]. Ligand binding to Ptch
ultimately leads to activation of the Gli transcription factor family,
which in vertebrate consists of Gli1, Gli2, and Gli3, by post-
translational proteolytic processing [17]. Activated Gli translocates
into the nucleus and subsequently activates or represses target
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genes expression [18]. Among the three Gli transcription factors in
mammal, Gli1 and Gli2 are the major activating Gli (Gliact),
whereas proteasome cleaved Gli3 is the major repressor Gli (Glirep)
[19]. In human malignancies, aberrant activation of HH pathway
could be resulted from sustained increase in endogenous
expression of HH ligand (ligand-dependent mechanisms) or
mutations of Ptch or Smo in the pathway (ligand-independent
mechanisms) [20].
In Drosophila, Costal-2 (Cos2) is a Hedgehog signalling
component, relaying signals from Smo to Cubitus interruptus
(Ci, the only Gli in Drosophila), Fused (Fu), and microtubule [21].
The kinesin protein Kif7 is the mammalian homolog of Cos2.
Genetic studies revealed that the function of Kif7 as a regulator of
Gli was conserved in mammal [22]. Homozygous knock-out mice
of Kif7 exhibited exencephaly and polydactyly which are
phenotypes reminiscent of Gli3 knockout [23,24], suggesting a
predominant suppressor role of Kif7 in HH signalling during
development. However, Ptch-Kif7 double mutant exhibited a
milder phenotype than Ptch knockout (a HH hyper-activation
phenotype), suggesting that Kif7 may also participate in HH
pathway activation [24].
In this study, the expression profile of activator/repressor Gli
transcription factors and regulator (Gli1, Gli2, Gli3 and Kif7) in
GTD was assessed. The functional implications of Kif7 dysregu-
lation on cell proliferation, apoptosis, and cell migration/invasion
were also investigated.
Materials and Methods
Clinical samples and cell lines
Eighty-seven trophoblast samples, including 19 normal first
trimester placentas, 10 term placentas, four choriocarcinomas, 50
hydatidiform moles consisting of 11 partial moles and 39 complete
moles were retrieved from the archive of the Department of
Pathology, The University of Hong Kong, Queen Mary Hospital.
First trimester placenta tissues and molar tissues were obtained by
suction evacuation while samples of term placentas were collected
after uneventful delivery. GTD cases were diagnosed following the
commonly used and acceptable histological morphology criteria as
previously described [7]. Three human choriocarcinoma cell lines,
JEG-3, JAR, and BeWo, were obtained from American type
culture collection (Rockville, MD, USA). A normal trophoblastic
cell lines TEV-1 was established by immortalization of villous and
extravillous trophoblasts by HPV16 E6/E7 gene transfection [25].
Another immortalized trophoblastic cell line HTR-8/SVneo was
contributed by Professor Peeyush K. Lala [26]. All cell lines were
cultured in Minimum Essential Medium Eagle (Sigma, St. Louis,
MO) supplemented with 10% foetal calf serum and 100 U/ml
penicillin and streptomycin.
Ethics Statement
Ethics approval for the use of tissue samples in this study has
been obtained from Institutional Review Board of the University
of Hong Kong/Hospital Authority Hong Kong West Cluster
(HKU/HA HKW IRB). The tissue samples used in this study were
archival patient samples stored after their use for diagnosis has
been completed. The need for written informed consent from
individual patient was waived by HKU/HA HKW IRB.
RNA extraction and reverse transcription quantitative
PCR
RNA extraction was performed on cell lines or frozen placental
tissues using TRIzol (Life Technologies) according to the
manufacturer’s instruction. 2.5 mg of total RNA was reverse
transcribed using Superscript III Reverse Transcriptase (Life
Technologies). Reverse transcription quantitative PCR (RT-
qPCR) was performed as previously described [7]. Gene
expression levels relative to one of the samples (calibrator) were
calculated using the DDCt method using GAPDH as the
normalization internal control gene. Sequences of primers used
were shown in Table 1.
Generation of CCA cell lines with stable overexpression
of Kif7
The expression plasmid pEF6/V5-His-Kif7 was generated by
subcloning the Kif7 ORF from pCR-BluntII-TOPO-Kif7 (Im-
agenes) into pEF6/V5-His-TOPO (Life Technologies) using BstXI
sites. The CCA cell lines JEG-3 and JAR were transfected with
pEF6/V5-His-Kif7 or the control vector pEF6/V5-His using
Lipofectamine 2000 (Life Technologies). Pooled stable clones were
selected by 10 mg/ml blasticidin S.
Knockdown of Kif7 using siRNAs
Control and Kif7 siRNAs were purchased from IDT (Singa-
pore) (Cat# HSC.RNAI.N198525.12). The siRNAs were trans-
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fected into HTR-8/SVneo using Lipofectamine 2000 (Life
Technologies) according to the manufacturer’s instruction.
Protein Extraction and western blotting
Cells were lysed with RIPA buffer with 2 mM N-ethylmalei-
mide, 2 mM PMSF, 1 mM sodium orthovanadate, 0.1 mM
sodium okadat. Protein concentration was determined by protein
assay (Bio-Rad). A total of 20 mg protein was resolved by SDS-
PAGE and transferred to polyvinylidene difluoride membrane.
Antibodies used for detection included anti-Kif7 (Abcam ab95884)
and anti-actin (Sigma A5060).
MTT assay
Stably transfected cells were seeded in 96-well plates at a density
of 16104 cell/well. MTT solution was added to each well 24 hours
after seeding and incubated at 37uC for 4 hours. Precipitate was
dissolved by dimethyl sulfoxide solution. Absorbance at 590 nm
was measured by a plate reader.
Figure 1. Hedgehog signalling components were differentially regulated in normal and GTD placentas. (A) The levels of Gli
transcription factors and Kif7 transcripts in tissue samples of first trimester, term, hydatidiform mole, and choriocarcinoma placentas were compared
with RT-qPCR. (B) The level of Kif7 was compared in immortalized trophoblast cell lines (TEV-1, HTR-8/SVneo) and choriocarcinoma cell lines JEG-3,
JAR, and BeWo with RT-qPCR (left panel) and western blotting (right panel). Data represent the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0108248.g001
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TUNEL assay
TUNEL cell death detection assay (Roche) was performed
according to manufacturer’s instruction. Briefly, cells were plated
on round glass cover slips in 24-well plates and the cover slips were
collected 48 hours after plating. Cells were fixed with 4%
paraformaldehyde and permeablized with 0.1% Triton-X. Cells
were then incubated in the TUNEL reaction mixture containing
TdT and fluorescein-dUTP. Slides were observed under a
fluorescence microscope. Apoptotic cell death of each sample
was quantified by apoptotic index (number of apoptotic cells/
number of total counted cells6100%).
Migration/Invasion assay
JEG-3, JAR, or HTR-8/SVneo were trypsinized and resus-
pended in serum-free MEM. 2.56105 cells/well were plated in the
upper chambers of gelatin-coated transwells. The transwells were
then placed in 24-well plates containing MEM. The inserts were
harvested at 24 hours for JAR, 66 hours for JEG-3, and 48 hours
for HTR-8/SVneo and stained with crystal violet after non-
migrated cells were removed.
Statistical analysis
Statistical significances of the differences between expression
levels determined by RT-qPCR and differences in cell number in
MTT assay were tested with two-tailed Student’s T-test.
Results
Gli transcription factors and the Gli regulator Kif7 are
downregulated in GTD
The expression levels of Gli1, Gli2, and Gli3 transcripts from
first trimester placenta, term placenta, HM, and choriocarcinoma
were compared using RT-qPCR. Both Gli1 and Gli2 showed a
decreasing trend across the samples in the order of first trimester
placenta.term placenta.HM.CCA (Figure 1A). Gli3 level was
found to be markedly reduced in HM and CCA when compared
with normal placentas although no significant difference between
first-trimester and term placenta was detected (Figure 1A).
Unlike the Gli transcription factors, Kif7 showed significant
reduction only in CCA samples (Figure 1A). Concurring signifi-
cant reduction of Kif7 expression was also demonstrated in the
three CCA cell lines JEG-3, JAR, and BeWo when compared with
normal trophoblast cell lines TEV-1 and HTR-8/SVneo (Fig-
ure 1B).
Kif7 overexpression suppressed cell growth and
migration
JEG-3 and JAR were stably transfected with pEF6/V5-His-Kif7
or the control vector pEF6/V5-His. Efficiency of transfection was
evaluated by RT-qPCR which showed that JAR-Kif7 and JEG-3-
Kif7 expressed about 1000-fold and 10000-fold more Kif7
transcript respectively when compared with cells stably transfected
with the control plasmid (Figure 2A). Kif7 protein expression as
analysed by western blotting also showed that JEG-3-Kif7 and
JAR-Kif7 expressed much higher level of Kif7 than did JEG-3-
Vec and JAR-Vec respectively (Figure 2A).
Figure 2. Kif7 overexpression in JEG-3 and JAR dysregulated other HH signalling components. (A) Left panel: RT-qPCR measurement of
Kif7 transcript expression in JEG-3 or JAR cells stably transfected with empty vector (JEG-3-Vec, JAR-Vec) or Kif7 expression plasmid (JEG-3-Kif7, JAR-
Kif7). Data represent the mean 6 SEM of three independent experiments. Right-panel: western blot analysis of Kif7 protein expression in the stably
transfected cells. (B) RT-qPCR measurement of Gli1, Gli2, Gli3, and Ptch1 transcripts in the stably transfected cells. Data represent the mean 6 SEM of
three independent experiments.
doi:10.1371/journal.pone.0108248.g002
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Next, Gli1, Gli2, Gli3 and Ptch1 transcript levels were
quantified by RT-qPCR in CCA cell lines stably transfected with
Kif7 to assess HH pathway activity and possible interaction with
Kif7. We observed a statistically significant decrease in the
expression of Gli1 in both JEG-3 and JAR when Kif7 was
overexpressed (Figure 2B and 2C). On the other hand, no obvious
change in Gli3 and Ptch1 expression was observed in JEG-3-Kif7
and JAR-Kif7. Gli2 expression was slightly downregulated in JEG-
3-Kif7 but markedly upregulated in JAR-Kif7 (Figure 2B and 2C).
The cell growth of JAR-Kif7 and JEG-3-Kif7 was compared
with the control cells using MTT assay over a culturing period of
three days. As shown in Figure 3A, JEG-3-Kif7 and JAR-Kif7
grew significantly slower than their control counterparts.
TUNEL assay was performed to assess the apoptotic indices of
the stably transfected cells. Both JEG-3 and JAR transfected with
the control vector has very low percentage of cell undergoing
apoptosis (0.24% and 0.4%, respectively, Figure 3B and 3C). We
observed a slight increase in the percentage of cells undergoing
apoptosis in JAR-Kif7 (2.98%, Figure 3B and 3C), and a large
increase of apoptotic cell in JEG-Kif7 (38.52%, Figure 3B and
3C).
Kif7 manipulation affected cell migration and invasion
Trophoblasts were known to exhibit varying tendency to invade
and metastasize. Therefore we tested the effect of Kif7 overex-
pression on JEG-3 and JAR cell migration and invasion by
transwell migration/invasion assay. Cells migrated through the
gelatin coated membranes were fixed and stained with crystal
violet 24 hours (for JAR-Vec and JAR-Kif7) or 66 hours (for JEG-
3-Vec and JEG-3-Kif7) after seeding. JAR-Vec and JEG-3-Vec
readily migrated through membranes (Figure 3D). We observed
that JAR-Kif7 and JAR-Vec exhibited similar ability to migrate,
whereas Kif7 overexpression drastically inhibited JEG-3 cell
migration (Figure 3D).
Mutation in the KIF7 locus has been linked to Joubert
syndrome which is a rare, inherited developmental disorder
characterized by cerebellar hypoplasia, ataxia, psychomotor delay,
and an altered respiratory pattern in the neonatal period. At
cellular level, knockdown of Kif7 in polarized retinal epithelial
cells led to a dispersed staining pattern of the Golgi apparatus,
abnormal centrosome duplications and a reduced number of
ciliated cells [27]. Downregulation of Kif7 in CCA may hence
affect the ciliogenesis in CCA trophoblasts. We tried to investigate
this possibility by monitoring the relative transcript level of a
transcriptional regulator of ciliogenesis regulatory factor X 3
(RFX3) in Kif7 stably transfected JEG-3 and JAR. RFX3 is
responsible for the transcription of many structural proteins of the
primary cilia [28]. Kif7 overexpression in JEG-3 and JAR
significantly increased the expression of RFX3 (Figure 3E).
To confirm the effect of Kif7 on trophoblast cell migration, Kif7
was knockdown in HTR-8/SVneo using siRNA approach. HTR-
8/SVneo expressed much higher level of Kif7 compared with
Figure 3. Kif7 overexpression in JEG-3 and JAR led to slower growth rate, increased apoptosis, and reduced mobility. (A) The cell
growth of stably transfected cells was measured by MTT assay over three days of culture. Data represented the mean 695% CI of three independent
experiments. * : p,0.01. (B) & (C) Apoptosis in stably transfected cells was detected with TUNEL assay and quantified as percentage of cell being
TUNEL positive. (D) Stably transfected JEG-3 or JAR were seeded in the upper chamber of transwells and allowed to migrate through gelatin-coated
membrane for 24 hours (JAR) or 66 hours (JEG-3). Migrated cells were stained with crystal violet. (E) The relative expression of RFX-3 was measured
with RT-qPCR in stably transfected JEG-3 and JAR. Data represent the mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0108248.g003
Figure 4. Knockdown of Kif7 in HTR-8/SVneo increased cell growth and cell mobility. (A) HTR-8/SVneo was transiently transfected with
control siRNA and two siRNAs against Kif7. The expression of Kif7 in transfected cell was assessed with western blotting. (B) The growth of transfected
HTR-8/SVneo was monitored over two days with MTT assay. Data represented the mean 695% CI of three independent experiments. * : p,0.01. (C)
siRNA transfected cells were seeded in the upper chamber of transwells and allowed to migrate through gelatin-coated membrane for 48 hours.
Migrated cells were stained with crystal violet.
doi:10.1371/journal.pone.0108248.g004
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JEG-3 and JAR (Figure 1B). Two siRNAs were found to markedly
reduce the level of Kif7, with si#2 displayed more potent
inhibition of Kif7 expression (Figure 4A). Knocking down Kif7 in
HTR-8/SVneo significantly increased the cell growth rate of
HTR-8/SVneo (Figure 4B).
HTR-8/SVneo transfected with control siRNA readily migrat-
ed through the membrane after 48 hours. Transfection with si#2
drastically increased the number of cell migrated through the
membrane, whereas si#1 showed a less obvious effect (Figure 4B).
Discussion
HH dysregulation is involved in GTD pathogenesis
Gestational trophoblastic disease, although rare and usually
curable, represents an intriguing class of human malignancy.
While the cytogenetic mechanisms leading to HM have been fairly
well defined, it is unclear how CCA may develop spontaneously
from HM or from apparently unremarkable pregnancies. Our
previous works have suggested GTD, like many other solid
tumours, involves stem cell dysregulation [7–10]. The HH
signalling pathway has long been known to be important for stem
cell self-renewal by contributing to the establishment of stem cell
niche [29]. Activation of HH signalling is evident in various
human malignancies [30]. However the activity of the pathway in
GTD is not known.
The current study described, as far as we know, the first
investigation of the role of HH signalling pathway in GTD. We
first examined the expression of several components of the HH
pathway in clinical samples; then investigated the effect of Kif7, a
HH signalling component found dysregulated in clinical samples,
in two invitro models of CCA, JEG-3 and JAR. Our findings
suggest HH signalling is indeed dysregulated in GTD. We focused
on the role of Kif7, which exhibited a distinct expression pattern in
GTD compared with the Gli transcription factors. Kif7 was found
to profoundly inhibit the cell growth and to induce apoptosis of
JEG-3 and JAR (Figure 3A–C). Moreover, Kif7 could suppress
cell migration and invasion of CCA cells (Figure 3D). These effects
were confirmed in knockdown of Kif7 in HTR-8/SVneo, a non-
tumorigenic trophoblast model (Figure 4) [26]. These findings
suggest Kif7 downregulation to be playing a significant role in
trophoblast carcinogenesis.
Kif7 dysregulation may represent a novel mechanism of
HH signalling alteration
Hedgehog signalling pathway is frequently activated in various
kinds of malignancies and is often found to contribute to pro-
survival mechanisms of cancer cells. HH signalling may be
activated either by overexpression of HH ligand, or by disabling
mutation of Ptch or activating mutation of Smo [20]. Our
discovery that Kif7 is downregulated in CCA may represent a
novel mechanism of HH signalling dysregulation in cancer.
Although being the mammalian homolog of Drosophila Cos2,
the essential upstream signalling component Ci, the involvement
of Kif7 in HH signalling was not established until fairly recently
[22–24]. Kif7 knock-out mice exhibited exencephaly and
polydactyly which are phenotypes reminiscent of Gli3 knockout,
suggesting that Kif7 predominantly acts as a suppressor of HH
signalling during development [23,24]. Our findings that Kif7 is
downregulated imply that HH signalling is activated in CCA.
Kif7 is a member of the kinesin 4 superfamily. It has been found
to play important roles in Hedgehog signalling pathway, primary
cilium formation, and embryological development. Kif7 mutations
or dysregulation was found in diseases such as Joubert syndrome
[31]. However, reports on the status or role of Kif7 in human
malignancies have been scanty [32]. Our real time PCR
experiments demonstrated reduced Kif7 expression in both
clinical samples and cell lines of CCA when compared with
normal placental trophoblasts or hydatidiform moles (Figure 1).
These findings suggested that Kif7 may be important for
progression to choriocarcinoma and may serve as a potential
genetic marker, especially during surveillance after primary
evacuation of molar pregnancy. The usefulness of Kif7 in
predicting clinical outcome of GTD needs further investigation
on larger number of samples.
Dysregulation of Gli transcription factors in GTD
Kif7 had been shown to be a critical regulator of the Hedgehog
signalling pathway through regulation of Gli transcription factors
[23,24]. In this study, we provided preliminary data suggesting
that Kif7 may regulate certain Gli transcription factors at
transcript level (Figure 2B and 2C). Gli1 was consistently
downregulated by Kif7 overexpression in CCA cell lines. Gli1 is
important for the oncogenic effect of HH signalling [33]. In fact,
Gli1 was first identified as an amplified, highly expressed factor in
human glioma [34], and an oncogenic transcription factor being
responsible for the carcinogenesis of sporadic basal cell carcinoma
[35]. However, in GTD clinical samples, the expression of Gli1
transcription factors was found to be reduced, and was particularly
low in CCA (Figure 1A). This suggests the existence of multiple
regulation mechanisms of Gli1 expression in CCA and Kif7
dyregulation is not the dominant mechanism.
The Gli code hypothesis postulates that the three vertebrate Gli
transcription factors act together in responding cells to dictate the
outcome of HH signalling and other signalling crosstalks [19].
Among the three Gli transcription factors in mammal, Gli1 and
Gli2 are the major activating Gli (Gliact), whereas proteasome
cleaved Gli3 is the major repressor Gli (Glirep) [19]. Interestingly,
Gli3 was also strongly downregulated in GTD (Figure 1A),
suggesting that it might be a mechanism of elevated HH signaling
activity.
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